Pulmovant logo

Pulmovant

Executive Assistant, Pulmovant at Pulmovant

Remote, USFull-timeRemoteCEOPosted 4 days ago
Apply with Pipeline

About the Role

<p></p> <div class="p-pdf_viewer_thumbnail"> <div data-page-number="1">&nbsp;</div> </div> <div id="pdf_viewer" class="p-pdf_viewer__content"> <div class="p-pdf_iframe__page" data-page-number="1"> <div class="textLayer" data-main-rotation="0"> <p><span data-contrast="auto">Pulmovant is a Roivant-backed clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. Pulmovant’s first investigational candidate, mosliciguat, is designed to provide a novel, once-daily, inhaled treatment option for patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Mosliciguat is a potential first-in-class soluble guanylate cyclase activator with a differentiated mechanism of action currently being evaluated in the Phase 3 PHrontier global clinical trial in PH-ILD, but with potential broad applicability across the PH and ILD disease landscape. </span><span data-ccp-props="{}">&nbsp;</span></p> <p><span data-contrast="auto">Pulmovant recently announced positive results from its Phase 2 PHocus study evaluating mosliciguat for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), a progressive and life-threatening condition with significant unmet medical needs for patients. PHocus met both primary and secondary endpoints including the highest ever reported pulmonary vascular resistance (PVR) reduction in any randomized controlled PH trial. The robust results, in conjunction with mosliciguat’s once-daily, inhaled administration and potential first-in-class sGC activator profile, strongly position it as a potential single agent treatment and combination therapy for patients with PH-ILD.  These data represent a significant advancement in a devastating disease that affects ~200,000 patients with no or very limited treatment options. A Phase 3 trial is currently underway. More details can be found in the press release </span><a href="https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat"><span data-contrast="none"><span data-ccp-charstyle="Hyperlink">here</span></span></a><span data-contrast="auto">.</span><span data-ccp-props="{}">&nbsp;</span></p> <p><span data-contrast="auto">As part of the Roivant family of companies, Pulmovant leverages the power of collaboration and innovation to drive progress.</span><span data-ccp-props="{}">&nbsp;</span></p> <p><span data-contrast="auto">For more information, please visit </span><a href="https://www.pulmovant.com/"><span data-contrast="none"><span data-ccp-charstyle="Hyperlink">https://www.pulmovant.com</span></span></a><span data-contrast="auto">.</span><span data-ccp-props="{}">&nbsp;</span></p> <p><strong><span data-contrast="auto">About Roivant:</span></strong><span data-ccp-props="{}">&nbsp;</span></p> <p><span data-contrast="auto">Roivant (Nasdaq: ROIV) is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant’s pipeline includes LISRAYA™ (brepocitinib), a potent small molecule inhibitor of JAK1 and TYK2 FDA-approved for the treatment of dermatomyositis in adult patients and also in late-stage development for the treatment of non-infectious uveitis, cutaneous sarcoidosis and lichen planopilaris; IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. We advance our pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies. For more information, visit </span><a href="http://www.roivant.com/"><span data-contrast="none"><span data-ccp-charstyle="Hyperlink">www.roivant.com</span></span></a><span data-contrast="auto">.&nbsp;</span><span data-ccp-props="{}">&nbsp;</span></p> </div> <div class="textLayer" data-main-rotation="0"> <p><strong>Position: </strong>Executive Assistant</p> <p>Candidates based in NY, NJ, or MA are strongly preferred.</p> <p><strong>Summary:</strong>&nbsp;</p> <p>The successful candidate will provide high level administrative, communication and project management support in all facets of the daily business routine for team of senior leaders in the clinical and clinical trial/program group. The candidate will be flexible and open to unfamiliar assignments with excellent problem solving and critical thinking skills. Must handle multiple workstreams with adaptable and efficient prioritization. Should be highly organized and work well both collaboratively and autonomously. Candidate will be highly resourceful, composed, and empathetic. Must thrive in a fast-paced, start-up environment and work well under the pressure of multiple competing requests within tight timelines.&nbsp;&nbsp;</p> <p><strong>Key</strong><strong> </strong><strong>Duties and Responsibilities&nbsp;</strong></p> <ul> <li>Handle heavy, complex,&nbsp;fluid&nbsp;calendar management,&nbsp;while proactively&nbsp;managing conflicts.&nbsp;</li> <li>Effectively engage&nbsp;with&nbsp;team by staying on top of key topics,&nbsp;areas of focus,&nbsp;and&nbsp;prioritizing appropriately.&nbsp;</li> <li>Handle&nbsp;meeting&nbsp;logistics&nbsp;for&nbsp;conferences,&nbsp;investor,&nbsp;and industry&nbsp;events, coordinating&nbsp;all aspects of participation.&nbsp;</li> <li>Work closely and under the supervision of the&nbsp;Director of Executive Operations, Office of&nbsp;The&nbsp;CEO.&nbsp;</li> <li>Work&nbsp;closely&nbsp;with&nbsp;team&nbsp;to&nbsp;stay&nbsp;well informed of upcoming commitments and responsibilities.&nbsp;</li> <li>Manage sensitive matters with&nbsp;a high level&nbsp;of confidentiality and discretion.&nbsp;</li> <li>Coordinate&nbsp;complex&nbsp;domestic and international travel arrangements, researching required&nbsp;passport,&nbsp;visa&nbsp;requirements,&nbsp;providing&nbsp;detailed&nbsp;itineraries.&nbsp;</li> <li>Prioritize conflicting needs; handle matters expeditiously and proactively, and take projects to successful completion, often with deadline pressures.&nbsp;</li> <li>Work cooperatively with the team&nbsp;of assistants&nbsp;in&nbsp;a&nbsp;positive&nbsp;partnership.&nbsp;&nbsp;</li> <li>Coordinate meeting&nbsp;logistics,&nbsp;conference rooms,&nbsp;remote participant&nbsp;access,&nbsp;catering,&nbsp;and&nbsp;meeting materials.&nbsp;</li> <li>Regularly&nbsp;interface with&nbsp;high-profile professionals on behalf of&nbsp;team.&nbsp;</li> <li>Responsive to emails/texts/phone calls, outside&nbsp;of&nbsp;normal business hours.&nbsp;</li> <li>Track,&nbsp;prepare&nbsp;and&nbsp;submit&nbsp;expenses, invoices and&nbsp;purchase orders,&nbsp;processing&nbsp;in a timely manner.&nbsp;&nbsp;</li> <li>Assist&nbsp;with personal requests as needed.&nbsp;</li> <li>Perform other related administrative tasks&nbsp;as assigned and&nbsp;required.&nbsp;</li> </ul> <p><strong>Education and Experience&nbsp;</strong></p> <ul> <li>Bachelor’s&nbsp;degree&nbsp;preferred.&nbsp;</li> <li>Minimum of&nbsp;8-10&nbsp;years’&nbsp;experience&nbsp;supporting senior level&nbsp;executives&nbsp;preferably&nbsp;in the&nbsp;R&amp;D/Pharmaceutical/Biotech industry,&nbsp;Finance/Investment&nbsp;industry&nbsp;or start-up&nbsp;</li> <li>Experience in a fast-paced,&nbsp;high-pressure&nbsp;environment&nbsp;</li> <li>Experience with Concur a plus.&nbsp;&nbsp;</li> </ul> <p><strong>Essential</strong><strong>&nbsp;</strong><strong>Skills and</strong><strong>&nbsp;</strong><strong>Abilities&nbsp;</strong></p> <ul> <li>Proactive, positive, energetic, and enthusiastic personality&nbsp;with a can-do attitude.&nbsp;</li> <li>Demonstrate alignment with company values&nbsp;while fostering a positive&nbsp;culture.&nbsp;</li> <li>Flexible and resilient with an eagerness&nbsp;to learn,&nbsp;receptive to&nbsp;constructive&nbsp;feedback.&nbsp;</li> <li>Team-oriented&nbsp;with&nbsp;a collaborative&nbsp;approach.&nbsp;</li> <li>Ability to learn quickly and adapt to change with the&nbsp;skill&nbsp;to shift direction&nbsp;rapidly.&nbsp;</li> <li>Detail&nbsp;oriented with excellent time management and organizational skills.&nbsp;</li> <li>High level&nbsp;of integrity,&nbsp;discretion,&nbsp;professionalism,&nbsp;and confidentiality.&nbsp;&nbsp;</li> <li>Ability to&nbsp;anticipate&nbsp;the needs of the executive, the team, and the company.&nbsp;</li> <li>Ability to&nbsp;work in a&nbsp;fast paced,&nbsp;high-energy&nbsp;environment.&nbsp;</li> <li>Ability to&nbsp;prioritize and&nbsp;manage multiple assignments and responsibilities.&nbsp;&nbsp;</li> <li>Approach challenges with a positive and&nbsp;solutions-minded perspective.&nbsp;</li> <li>Tech-savvy and resourceful.&nbsp;</li> <li>Excellent written and verbal skills.&nbsp;</li> <li>24/7 mindset&nbsp;required.&nbsp;</li> </ul> <p>&nbsp;</p> <p></p> <p><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">Pulmovant</span><span data-ccp-parastyle="No Spacing"> provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.&nbsp;</span></span><span data-ccp-props="{}">&nbsp;</span></p> <p><span data-contrast="auto"><span data-ccp-parastyle="No Spacing">We will not accept unsolicited resumes </span><span data-ccp-parastyle="No Spacing">nor</span><span data-ccp-parastyle="No Spacing"> outreach from agencies. Please do not send agency resumes to our website or Roivant Sciences and affiliated employees. Thanks!</span></span><span data-ccp-props="{}">&nbsp;</span></p> </div> </div> </div> <p></p>